Swiss National Bank
LCTX icon

Swiss National Bank’s Lineage Cell Therapeutics LCTX Stock Holding History

Swiss National Bank’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-209,486
Closed -$274K – 2559
2019
Q1 		$274K Buy
209,486
+45,200
+28% +$56.2K ﹤0.01% 2470
2018
Q4 		$150K Sell
164,286
-23,493
-13% -$36K ﹤0.01% 2530
2018
Q3 		$386K Hold
187,779
– – ﹤0.01% 2455
2018
Q2 		$338K Hold
187,779
– – ﹤0.01% 2497
2018
Q1 		$442K Buy
187,779
+22,517
+14% +$52.8K ﹤0.01% 2404
2017
Q4 		$311K Buy
165,262
+38,862
+31% +$84.9K ﹤0.01% 2487
2017
Q3 		$314K Hold
126,400
– – ﹤0.01% 2478
2017
Q2 		$348K Hold
126,400
– – ﹤0.01% 2498
2017
Q1 		$382K Buy
126,400
+19,888
+19% +$56.5K ﹤0.01% 2444
2016
Q4 		$336K Hold
106,512
– – ﹤0.01% 2498
2016
Q3 		$363K Hold
106,512
– – ﹤0.01% 2438
2016
Q2 		$243K Buy
106,512
+26,959
+34% +$66.1K ﹤0.01% 2542
2016
Q1 		$191K Buy
79,553
+14,629
+23% +$32.6K ﹤0.01% 2560
2015
Q4 		$215K Hold
64,924
– – ﹤0.01% 2565
2015
Q3 		$157K Buy
64,924
+10,407
+19% +$26.9K ﹤0.01% 2523
2015
Q2 		$160K Buy
+54,517
New +$211K ﹤0.01% 2559
2014
Q2 		– Sell
-35,188
Closed -$93K – 2540
2014
Q1 		$93K Buy
35,188
+12,266
+54% +$36.1K ﹤0.01% 2483
2013
Q4 		$67K Hold
22,922
– – ﹤0.01% 2500
2013
Q3 		$70K Hold
22,922
– – ﹤0.01% 2473
2013
Q2 		$73K Buy
+22,922
New +$73.4K ﹤0.01% 2490

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Swiss National Bank's LCTX Position: Q2 2019 in Review

Swiss National Bank sold out of Lineage Cell Therapeutics (LCTX) in Q2 2019, closing a stake of 209,486 shares — an estimated $274K sold.

Swiss National Bank first reported a position in LCTX in Q2 2013 and held it in 20 quarters. The position peaked at $442K in Q1 2018. 107 funds tracked by Wall St. Rank hold LCTX as of Q2 2019.

  • Swiss National Bank reported no remaining Lineage Cell Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Swiss National Bank sold 209,486 Lineage Cell Therapeutics shares in Q2 2019, an estimated $274K.
  • Swiss National Bank first reported a position in Lineage Cell Therapeutics in Q2 2013 and held it in 20 quarters.
  • Swiss National Bank's Lineage Cell Therapeutics position peaked at $442K in Q1 2018.
  • 107 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q2 2019.

Based on Swiss National Bank's 13F filing for Q2 2019, filed 2 Aug 2019.